Merkel cell carcinoma: An often-lethal, virus-driven cancer provides insights into adaptive and innate anti-tumor immunity
January 25, 2022
This is a presentation given by Paul Ngheim to University of Washington’s Department of Immunology. It is a scientific, detailed summary of how our understanding of the role of the immune system in Merkel cell carcinoma has developed over the past decade. It highlights how our current immune therapies came about and several areas of current immunology research that we hope could lead to improved therapies in the not-too-distant future.